Connection

Aldo Maggioni to Mineralocorticoid Receptor Antagonists

Back to Details
This is a "connection" page, showing publications Aldo Maggioni has written about Mineralocorticoid Receptor Antagonists.
Aldo Maggioni
Connection Strength
0.433
Mineralocorticoid Receptor Antagonists
  1. Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry. Eur J Heart Fail. 2018 01; 20(1):100-110.
    View in: PubMed
    Score: 0.151
  2. Heart failure oral therapies at discharge are associated with better outcome in acute heart failure: a propensity-score matched study. Eur J Heart Fail. 2018 02; 20(2):345-354.
    View in: PubMed
    Score: 0.150
  3. Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial. Circ Heart Fail. 2018 07; 11(7):e004962.
    View in: PubMed
    Score: 0.040
  4. Galectin-3 and the Mineralocorticoid Receptor Antagonist Canrenone in Mild Heart Failure. Circ J. 2017 Sep 25; 81(10):1543-1546.
    View in: PubMed
    Score: 0.038
  5. Clinical and prognostic value of spot urinary creatinine in chronic heart failure-An analysis from GISSI-HF. Am Heart J. 2017 Jun; 188:189-195.
    View in: PubMed
    Score: 0.037
  6. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005]. G Ital Cardiol (Rome). 2007 Feb; 8(2):102-6.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.